Elderly women with breast cancer often die due to other causes regardless of primary endocrine therapy or primary surgical therapy

Breast. 2011 Aug;20(4):365-9. doi: 10.1016/j.breast.2011.01.013. Epub 2011 Feb 15.

Abstract

Survival and cause of death was investigated for Primary Surgical Therapy (PST) and Primary Endocrine Therapy (PET). Of women aged ≥75 years 113 patients received PET, 233 patients underwent PST. PST gave better survival, although this group was younger (p < 0.001). During follow-up the percentage of deaths due to breast cancer was similar and stable in both groups. Increased age was associated with a higher risk on death due to other causes (HR 1.11; CI 1.07-1.14), not on death due to breast cancer (HR 0.94; CI 0.87-1.01). The association of type of treatment and death due to breast cancer was not different between both groups in univariate analyses (HR 0.78; CI 0.44-1.39). In the multivariate model this non-significance remained after correcting for tumor size and age (HR 0.68; CI 0.33-1.42). Treatment should not be based merely on surgical treatment. PET may be an acceptable alternative.

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / mortality*
  • Breast Neoplasms / therapy*
  • Cause of Death
  • Combined Modality Therapy
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Mastectomy / statistics & numerical data*
  • Netherlands
  • Prognosis
  • Risk Factors
  • Survival Analysis
  • Women's Health*

Substances

  • Antineoplastic Agents, Hormonal